Opportunity
DIBBS #SPE2DP-26-T-3502
DLA Solicits Moxifloxacin Hydrochloride Tablets (400 mg) for Military Medical Supply
Posted
May 21, 2026
Respond By
May 26, 2026
Identifier
SPE2DP-26-T-3502
NAICS
325412
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA is soliciting Moxifloxacin Hydrochloride Tablets for military medical supply: - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA - OEMs (Original Equipment Manufacturers): - TEVA PHARMACEUTICALS USA, INC. (NDC00093-7387-56) - RISING PHARMA HOLDINGS, INC. (NDC57237-0156-30) - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - NSN: 6505-01-503-4772 / Part Number: 6505015034772 - Quantity: 17 bottles - Notable Requirements: - Delivery to Rose Barracks, Vilseck, Germany (FOB destination) - Strict packaging, labeling, and shelf-life (36 months, non-extendable) requirements - Compliance with Medical Marking Standard No. 1A - Adherence to Berry Amendment and Buy American Act - Delivery required within 10 days of award - Includes FAR/DFARS clauses for hazardous materials, cybersecurity, and small business programs
Description
MOXIFLOXACIN HYDROC (QTY: 17, NSN: 6505-01-503-4772, Purchase Request: 7016859748) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.